About Prilenia
Prilenia Therapeutics, a clinical-stage biotech company focused on the urgent mission of developing novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, is looking for a Vice President, Head of Market Access, Europe, to join its team in Europe.
We are a flexible, fast-moving team that is quickly advancing a potential therapy poised to have major impact on the lives of patients and their families. Our lead product candidate, pridopidine, holds Orphan Drug Designation in both Huntington’s disease (HD) and Amyotrophic lateral Sclerosis (ALS) in the U.S. and EU, as well as Fast Track designation from the FDA for the treatment of HD. Prilenia is working on preparing for a potential regulatory filing for HD and for starting a global phase 3 in ALS with pridopidine.
Pridopidine has the potential to be the first treatment to address HD disease clinical progression. Prilenia also believes pridopidine’s novel mechanism of action as a Sigma-1 receptor agonist gives it potential in numerous other neurological diseases.
About the role
The Head of Market Access, Europe will develop and execute the market access strategy across European markets. This position requires a strategic thinker with a deep understanding of the European healthcare landscape, pricing and reimbursement processes, and a passion for making a difference in the lives of patients with rare diseases.
This key role will be responsible for developing and executing market access strategies, leading value communication efforts and managing contracting initiatives to ensure optimal market positioning for pridopidine.
This role initially will report to the Chief Regulatory and Commercialization Officer but is expected to transition to the General Manager, Europe in the future.
Prilenia has offices in the U.S., Israel and The Netherlands. Prilenia is a highly virtual and flexible organization that is mostly remote and encourages team members to work in the ways that make them most effective, with a focus on our common goals and getting the job done.
Role and Responsibilities:
Market Access Strategy DevelopmentDevelop and implement a comprehensive market access strategy for pridopidine in different indications across Europe. Conduct landscape assessments to identify market access opportunities and challenges. Collaborate with cross-functional teams to integrate market access considerations into product development and launch plans. Pricing and Reimbursement Develop a global value dossier with Medical Affairs and Market Access, U.S. Lead the development of pricing strategies and national/local reimbursement dossiers for submission to health authorities and payers for European countries. Engage with health technology assessment (HTA) bodies, payers and other stakeholders to secure favorable reimbursement outcomes in Europe. Monitor and analyze changes in pricing and reimbursement policies across European markets. Stakeholder Engagement Build and maintain relationships with key stakeholders, including HTA agencies and payers. Represent the company at industry conferences, payer meetings and other relevant events. Develop and deliver compelling value propositions and evidence-based arguments to support product reimbursement and access. Work with Public Affairs/Government Affairs. Evidence Generation and Health Economics Lead development and implementation of HEOR strategy in collaboration with Medical Affairs, Scientific Communications and R&D. Work with external partners to develop health economic models, budget impact analysesand other tools to demonstrate the value of our therapies. Ensure the alignment of evidence generation plans with market access strategiesRegulatory and Compliance Ensure all market access activities comply with local regulations, industry standards and company policies. Stay informed of regulatory changes and updates in the healthcare environment that could impact market access. Team Leadership and Development Lead, mentor and develop a high-performing market access team across Europe. Foster a collaborative and inclusive team culture that encourages innovation and continuous improvement. Key Qualifications: Advanced degree in life sciences, health economics, business or a related field (e.g., MSc, MBA, PhD) Minimum 10 years of biopharma experience in market access, pricing, reimbursement and health economics, primarily in Europe, including significant experience in rare disease and/or neurology (additional commercial, start-up and launch experience are a plus) Strong understanding of the European healthcare systems and payer environments Proven track record in developing and executing successful market access strategies Experience using RWD/RWE Excellent communication, negotiation and interpersonal skillsAbility to work cross-functionally and influence without direct authority Analytical and strategic thinking with a problem-solving mindsetReliability and flexibility Leadership experience with a demonstrated ability to build and develop teamsDemonstrated ability to plan and execute in a nimble and lean launch settingWritten and verbal communication skills Proficiency in English is required; additional European languages are a plus Public affairs exposure is desirable Location/Time/Travel:
This is a full-time, mainly remote position in the EU. Flexible schedule with frequent calls across North America, Israel and Europe time zones. Up to 30% travel expected, including international.
